SHIELD: Surveillance of HR+/HER2- : Implementing ESR1m Long-term Monitoring and Detection in 1L aBC
Clinical trial NCT07701070 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07701070
- Sponsor
- AstraZeneca
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-09-30
- Primary completion
- 2029-03-30
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.